Delivery Order SPE2DB20D1110-SPE2DB25FK36U
- Not listed
- The Defense Logistics Agency awarded a $37,218.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on May 8, 2025, with an ultimate completion date of May 9, 2025. This non-competitive award, issued from the prime contractor's location in Conshohocken, Pennsylvania, represents a single delivery order fulfillment under an existing contract vehicle. Orencia (abatacept) is a biologic immunosuppressant medication used in the treatment of rheumatoid...
- The Defense Logistics Agency awarded a delivery order valued at $25,022.24 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic disease-modifying antirheumatic drug used to treat...
- The Defense Logistics Agency awarded a $6,473.76 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at the same address. Orencia (abatacept)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for Orencia ClickJect 125 mg/ml with a ceiling value of $9,679.46. This is a firm fixed price delivery order with no set-aside designation, reflecting open competitive procurement. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Performance will be...
- The Defense Logistics Agency awarded a $27,538.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml on April 21, 2025, with completion scheduled for April 22, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger prime vendor agreement with DLA Troop Support Medical. Orencia (abatacept) is a biologic medication commonly used to treat rheumatoid arthritis and other autoimmune conditions, with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $8,602.31 on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,338.74 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL pharmaceutical products on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Orencia ClickJect is a biologic medication used in the treatment of rheumatoid arthritis and other...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,423.65 by the Defense Logistics Agency on September 8, 2025, for the supply of Orencia ClickJect 125 mg/mL. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Orencia 125 mg/ml syringes valued at $14,495.04. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of...
- The Defense Logistics Agency awarded a $20,468.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside delivery order represents a continuation of pharmaceutical supply support to federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK36UDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $38,328.21 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support, enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems and other federal customers worldwide. Orencia (abatacept) is a biologic immunosuppressant medication used primarily for treating rheumatoid arthritis and other autoimmune conditions. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated extensive capability in fulfilling federal medical procurement needs through the DLA's medical supply chain. The company's contract portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order reflects the ongoing operational need within the Defense Health Agency and military healthcare systems to maintain access to critical biologic therapies for eligible beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.3k | 8/26/25 |